The Current State of Molecular Testing and Predictive Biomarkers in Gastrointestinal Malignancies

In this engaging satellite symposium expert faculty discuss current best practice for molecular testing of biomarkers to guide treatment decisions for patients with GI malignancies.

Share

Program Content

Activities

Biomarkers and ctDNA
Evolution of Biomarker Testing and Overview of Liquid Biopsy Using ctDNA
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 23, 2020

Expires: January 21, 2021

MMR/MSI and <i>NTRK</i> Fusions
Histology-Agnostic Biomarkers in Advanced Gastrointestinal Malignancies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 23, 2020

Expires: January 21, 2021

Biomarker-Driven Treatment
Biomarker-Driven Treatment of Advanced Gastrointestinal Malignancies
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 23, 2020

Expires: January 21, 2021

Faculty

cover img faculity

Pashtoon M. Kasi, MD, MS

Director 
Colon Cancer Research 
Weill Cornell Medicine
Director 
Liquid Biopsy Research 
Englander Institute of Precision Medicine 
New York, New Yotk

cover img faculity

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

cover img faculity

Michael J. Pishvaian, MD, PhD

Associate Professor
Sidney Kimmel Cancer Center
Johns Hopkins University
Director
Clinical Research, GI and Phase I Oncology in the National Capital Region
Johns Hopkins at Sibley Memorial Cancer Center
Washington, DC

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Array BioPharma

Bayer Healthcare Pharma

Merck Sharp & Dohme Corp.